Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
CLEC3B
Introduction
Tetranectin is a protein that in humans is encoded by the CLEC3B gene.[1]
External links
External links
- Human CLEC3B genome location and CLEC3B gene details page in the UCSC Genome Browser.
Further reading
Further reading
- Wewer UM, Albrechtsen R (1992). “Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer”. Lab. Invest. 67 (2): 253–62. PMID 1354271.
- Berglund L, Petersen TE (1992). “The gene structure of tetranectin, a plasminogen binding protein”. FEBS Lett. 309 (1): 15–9. doi:10.1016/0014-5793(92)80729-Z. PMID 1511740.
- Borregaard N, Christensen L, Bejerrum OW, et al. (1990). “Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase”. J. Clin. Invest. 85 (2): 408–16. doi:10.1172/JCI114453. PMC 296439. PMID 2298916.
- Clemmensen I (1990). “Interaction of tetranectin with sulphated polysaccharides and trypan blue”. Scand. J. Clin. Lab. Invest. 49 (8): 719–25. doi:10.3109/00365518909091550. PMID 2533389.
- Clemmensen I, Petersen LC, Kluft C (1986). “Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin”. Eur. J. Biochem. 156 (2): 327–33. doi:10.1111/j.1432-1033.1986.tb09586.x. PMID 3009181.
- Fuhlendorff J, Clemmensen I, Magnusson S (1988). “Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein”. Biochemistry. 26 (21): 6757–64. doi:10.1021/bi00395a027. PMID 3427041.
- Wewer UM, Ibaraki K, Schjørring P, et al. (1995). “A potential role for tetranectin in mineralization during osteogenesis”. J. Cell Biol. 127 (6 Pt 1): 1767–75. doi:10.1083/jcb.127.6.1767. PMC 2120295. PMID 7798325.
- Nielsen H, Clemmensen I, Kharazmi A (1993). “Tetranectin: a novel secretory protein from human monocytes”. Scand. J. Immunol. 37 (1): 39–42. doi:10.1111/j.1365-3083.1993.tb01662.x. PMID 8418471.
- Durkin ME, Naylor SL, Albrechtsen R, Wewer UM (1997). “Assignment of the gene for human tetranectin (TNA) to chromosome 3p22→p21.3 by somatic cell hybrid mapping”. Cytogenet. Cell Genet. 76 (1–2): 39–40. doi:10.1159/000134509. PMID 9154122.
- Nielsen BB, Kastrup JS, Rasmussen H, et al. (1997). “Crystal structure of tetranectin, a trimeric plasminogen-binding protein with an alpha-helical coiled coil”. FEBS Lett. 412 (2): 388–96. doi:10.1016/S0014-5793(97)00664-9. PMID 9256258.
- Kastrup JS, Nielsen BB, Rasmussen H, et al. (1998). “Structure of the C-type lectin carbohydrate recognition domain of human tetranectin”. Acta Crystallogr. D. 54 (Pt 5): 757–66. doi:10.1107/S0907444997016806. PMID 9757090.
- Jaquinod M, Holtet TL, Etzerodt M, et al. (2000). “Mass spectrometric characterisation of post-translational modification and genetic variation in human tetranectin”. Biol. Chem. 380 (11): 1307–14. doi:10.1515/BC.1999.166. PMID 10614823.
- Lorentsen RH, Graversen JH, Caterer NR, et al. (2000). “The heparin-binding site in tetranectin is located in the N-terminal region and binding does not involve the carbohydrate recognition domain”. Biochem. J. 347. Pt 1 (1): 83–7. doi:10.1042/0264-6021:3470083. PMC 1220934. PMID 10727405.
- Graversen JH, Jacobsen C, Sigurskjold BW, et al. (2001). “Mutational analysis of affinity and selectivity of kringle-tetranectin interaction. Grafting novel kringle affinity ontp the trtranectin lectin scaffold”. J. Biol. Chem. 275 (48): 37390–6. doi:10.1074/jbc.M004873200. PMID 10964919.
- Arvanitis DL, Kamper EF, Kopeikina L, et al. (2002). “Tetranectin expression in gastric adenocarcinomas”. Histol. Histopathol. 17 (2): 471–5. PMID 11962752.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Westergaard UB, Andersen MH, Heegaard CW, et al. (2003). “Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator”. Eur. J. Biochem. 270 (8): 1850–4. doi:10.1046/j.1432-1033.2003.03549.x. PMID 12694198.
- Anderson NL, Polanski M, Pieper R, et al. (2004). “The human plasma proteome: a nonredundant list developed by combination of four separate sources”. Mol. Cell. Proteomics. 3 (4): 311–26. doi:10.1074/mcp.M300127-MCP200. PMID 14718574.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Hermann M, Pirkebner D, Draxl A, et al. (2005). “In the search of potential human islet stem cells: is tetranectin showing us the way?”. Transplant. Proc. 37 (2): 1322–5. doi:10.1016/j.transproceed.2004.12.050. PMID 15848710.